[Table/Fig-3]:
Darifenacin | Trospium | |||||||
---|---|---|---|---|---|---|---|---|
Baseline score | 4 week score | Change in score from baseline | % change | Baseline score | 4 week score | Change in score from baseline | % change | |
Mean ± SD | Mean ± SD | |||||||
Frequency | 1.00 ± 0.74 | 0.20 ± 0.55 | -0.80 ± 0.76 | 80.00 | 0.53 ± 0.73 | 0.07 ± 0.25 | -0.47 ± 0.63 | 86.79 |
Nocturia | 2.80 ± 0.85 | 1.93 ± 1.08 | -0.87 ± 0.90 | 31.07 | 2.27 ± 1.01 | 1.33 ± 0.96 | -0.93 ± 0.79 | 41.41 |
Urgency | 3.40 ± 1.99 | 1.53 ± 2.22 | -1.87 ± 2.22 | 55.00 | 3.87 ± 1.61 | 1.47 ± 2.13 | -2.40 ± 2.19 | 62.02 |
Urge urinary incontinence | 2.67 ± 1.95 | 0.40 ± 1.04 | -2.27 ± 1.72 | 85.02 | 2.60 ± 2.03 | 1.13 ± 1.78 | -1.47 ± 1.96 | 56.54 |
OABSS | 9.87 ± 3.75 | 4.07 ± 3.29 | -5.80 ± 3.99 | 58.76 | 9.27 ± 3.21 | 4.00 ± 3.86 | -5.27 ± 2.98 | 56.85 |